Exploring the antiviral activities of the FDA-approved drug sulfadoxine and its derivatives against Chikungunya virus.
Daniel Oliveira Silva MartinsUriel Enrique Aquino RuizIgor Andrade SantosIgor Santos OliveiraMarco Guevara-VegaRaphael Enoque Ferraz de PaivaCamilla AbbehausenRobinson Sabino-SilvaPedro Paulo CorbiAna Carolina Gomes JardimPublished in: Pharmacological reports : PR (2024)
Collectively, our findings suggest that the addition of metal ions and/or Schiff base to SFX improved its antiviral activity against CHIKV.